西替利嗪滴剂与布地奈德吸入剂联用对哮喘急性发作患儿肺功能指标的影响

Effects of cetirizine drops combined with budesonide inhaler on pulmonary function in children with acute asthma

  • 摘要: 目的 探讨西替利嗪滴剂与布地奈德吸入剂联用对哮喘急性发作患儿的治疗效果。 方法 选取70例哮喘急性发作患儿作为研究对象,按随机双盲法分为2组,各35例。对照组采用布地奈德雾化吸入剂治疗,观察组采用西替利嗪滴剂联合布地奈德吸入剂治疗,比较2组患儿哮喘症状缓解效果、肺功能及不良反应。 结果 观察组治疗总有效率为97.14%, 高于对照组77.14%, 差异有统计学意义(P < 0.05); 治疗后,观察组最大通气量(MVV)、第1秒用力呼气量(FEV1)及用力肺活量(FVC)均高于对照组,差异有统计学意义(P < 0.05); 2组患儿均未出现严重不良反应,观察组不良反应发生率为8.57%, 对照组不良反应发生率为14.29%, 差异无统计学意义(P > 0.05)。 结论 西替利嗪滴剂联合布地奈德吸入剂治疗哮喘急性发作具有显著效果,可改善患儿肺功能,且无明显不良反应。

     

    Abstract: Objective To investigate the therapeutic effect of cetirizine drops combined with budesonide inhaler in children with acute asthma attack. Methods A total of 70 children with acute asthma attacks were selected in our hospital and divided into control group(n=35, budesonide aerosol inhalation)and observation group(n=35, cetirizine drops combined with budesonide inhalation)according to randomized double blind method. Efficacy of asthma symptoms remission, pulmonary function and adverse reactions of two groups were compared. Results The total effective rate of treatment in the observation group was higher than that in the control group(97.14%vs. 77.14%), and the maximum air volume(MVV), forced expiratory volume(FEV1)and forced vital capacity(FVC)after treatment were all higher than that in the control group(P < 0.05). There were no serious adverse reactions in the two groups, the incidence of adverse reactions was 8.57% in the observation group and 14.29%in the control group, but no significant difference was observed(P > 0.05). Conclusion The combination of cetirizine drops and budesonide inhalation in the treatment of acute asthma attack has significant effect, which can improve the children's lung function, and has no obvious adverse reactions.

     

/

返回文章
返回